Page 1442 - Hematology_ Basic Principles and Practice ( PDFDrive )

Chapter 79 Marginal Zone Lymphomas (Extranodal/Malt, Splenic, and Nodal) 1287.e1

REFERENCES 23. Weiler-Sagie M, Bushelev O, Epelbaum R, et al: (18)F-FDG avidity
in lymphoma readdressed: a study of 766 patients. J Nucl Med 51:25,
1. van Krieken JH, von Schilling C, Kluin PM, et al: Splenic marginal 2010.
zone lymphocytes and related cells in the lymph node: a morphologic 24. Treglia G, Zucca E, Sadeghi R, et al: Detection rate of fluorine-18-
and immunohistochemical study. Hum Pathol 20:320, 1989. fluorodeoxyglucose positron emission tomography in patients with
2. van den Oord JJ, de Wolf-Peeters C, Desmet VJ: The marginal marginal zone lymphoma of MALT type: a meta-analysis. Hematol
zone in the human reactive lymph node. Am J Clin Pathol 86:475, Oncol 2014.
1986. 25. Radaszkiewicz T, Dragosics B, Bauer P: Gastrointestinal malignant
3. Martin F, Kearney JF: Marginal-zone B cells. Nat Rev Immunol 2:323, lymphomas of the mucosa-associated lymphoid tissue: factors relevant
2002. to prognosis. Gastroenterology 102:1628, 1992.
4. Weill JC, Weller S, Reynaud CA: Human marginal zone B cells. Annu 26. Rohatiner A, d’Amore F, Coiffier B, et al: Report on a workshop
Rev Immunol 27:267, 2009. convened to discuss the pathological and staging classifications of
5. Harris NL, Jaffe ES, Stein H, et al: A revised European-American gastrointestinal tract lymphoma. Ann Oncol 5:397, 1994.
classification of lymphoid neoplasms: a proposal from the International 27. Ruskone-Fourmestraux A, Dragosics B, Morgner A, et al: Paris
Lymphoma Study Group. Blood 84:1361, 1994. staging system for primary gastrointestinal lymphomas. Gut 52:912,
6. Swerdlow SH, Campo E, Harris NL, et al, editors: WHO classifica- 2003.
tion of tumours of haematopoietic and lymphoid tissues, Lyon, 2008, 28. Kim YH, Willemze R, Pimpinelli N, et al: TNM classification system
International Agency for Research on Cancer. for primary cutaneous lymphomas other than mycosis fungoides and
7. Al-Saleem T, Al-Mondhiry H: Immunoproliferative small intestinal Sezary syndrome: a proposal of the International Society for Cutane-
disease (IPSID): a model for mature B-cell neoplasms. Blood 105:2274, ous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force
2005. of the European Organization of Research and Treatment of Cancer
8. A clinical evaluation of the International Lymphoma Study Group (EORTC). Blood 110:479, 2007.
classification of non-Hodgkin’s lymphoma. The Non-Hodgkin’s Lym- 29. Olszewski AJ, Castillo JJ: Survival of patients with marginal zone
phoma Classification Project. Blood 89:3909, 1997. lymphoma: analysis of the Surveillance, Epidemiology, and End Results
9. Zelenetz AD, Abramson JS, Advani RH, et al: NCCN Clinical Practice database. Cancer 119:629, 2013.
Guidelines in Oncology: non-Hodgkin’s lymphomas. J Natl Compr 30. Armitage JO, Weisenburger DD: New approach to classifying non-
Canc Netw 8:288, 2010. Hodgkin’s lymphomas: clinical features of the major histologic sub-
10. Thieblemont C, Felman P, Berger F, et al: Treatment of splenic marginal types. Non-Hodgkin’s Lymphoma Classification Project. J Clin Oncol
zone B-cell lymphoma: an analysis of 81 patients. Clin Lymphoma 3:41, 16:2780, 1998.
2002. 31. Stefanovic A, Lossos IS: Extranodal marginal zone lymphoma of the
11. Ruskone-Fourmestraux A, Fischbach W, Aleman BM, et al: EGILS ocular adnexa. Blood 114:501, 2009.
consensus report. Gastric extranodal marginal zone B-cell lymphoma 32. Nathwani BN, Anderson JR, Armitage JO, et al: Marginal zone B-cell
of MALT. Gut 60:747, 2011. lymphoma: a clinical comparison of nodal and mucosa-associated lym-
12. Bayerdorffer E, Neubauer A, Rudolph B, et al: Regression of primary phoid tissue types. Non-Hodgkin’s Lymphoma Classification Project. J
gastric lymphoma of mucosa-associated lymphoid tissue type after cure Clin Oncol 17:2486, 1999.
of Helicobacter pylori infection. MALT Lymphoma Study Group. 33. Remstein ED, Dogan A, Einerson RR, et al: The incidence and anatomic
Lancet 345:1591, 1995. site specificity of chromosomal translocations in primary extranodal
13. Levy M, Copie-Bergman C, Traulle C, et al: Conservative treatment marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue
of primary gastric low-grade B-cell lymphoma of mucosa-associated (MALT lymphoma) in North America. Am J Surg Pathol 30:1546,
lymphoid tissue: predictive factors of response and outcome. Am J 2006.
Gastroenterol 97:292, 2002. 34. Streubel B, Simonitsch-Klupp I, Mullauer L, et al: Variable frequencies
14. Montalban C, Castrillo JM, Abraira V, et al: Gastric B-cell mucosa- of MALT lymphoma-associated genetic aberrations in MALT lympho-
associated lymphoid tissue (MALT) lymphoma. Clinicopathological mas of different sites. Leukemia 18:1722, 2004.
study and evaluation of the prognostic factors in 143 patients. Ann 35. Thieblemont C, Bastion Y, Berger F, et al: Mucosa-associated lymphoid
Oncol 6:355, 1995. tissue gastrointestinal and nongastrointestinal lymphoma behavior:
15. Ruskone-Fourmestraux A, Lavergne A, Aegerter PH, et al: Predictive analysis of 108 patients. J Clin Oncol 15:1624, 1997.
factors for regression of gastric MALT lymphoma after anti-Helicobacter 36. Koch P, del Valle F, Berdel WE, et al: Primary gastrointestinal non-
pylori treatment. Gut 48:297, 2001. Hodgkin’s lymphoma: I. Anatomic and histologic distribution, clinical
16. Sackmann M, Morgner A, Rudolph B, et al: Regression of gastric features, and survival data of 371 patients registered in the German
MALT lymphoma after eradication of Helicobacter pylori is predicted Multicenter Study GIT NHL 01/92. J Clin Oncol 19:3861, 2001.
by endosonographic staging. MALT Lymphoma Study Group. Gastro- 37. Decaudin D, de Cremoux P, Vincent-Salomon A, et al: Ocular adnexal
enterology 113:1087, 1997. lymphoma: a review of clinicopathologic features and treatment options.
17. Steinbach G, Ford R, Glober G, et al: Antibiotic treatment of gastric Blood 108:1451, 2006.
lymphoma of mucosa-associated lymphoid tissue. An uncontrolled 38. Senff NJ, Noordijk EM, Kim YH, et al: European Organization for
trial. Ann Intern Med 131:88, 1999. Research and Treatment of Cancer and International Society for Cuta-
18. Perry C, Herishanu Y, Metzer U, et al: Diagnostic accuracy of PET/ neous Lymphoma consensus recommendations for the management of
CT in patients with extranodal marginal zone MALT lymphoma. Eur cutaneous B-cell lymphomas. Blood 112:1600, 2008.
J Haematol 79:205, 2007. 39. Fine KD, Stone MJ: Alpha-heavy chain disease, Mediterranean lym-
19. Alinari L, Castellucci P, Elstrom R, et al: 18F-FDG PET in mucosa- phoma, and immunoproliferative small intestinal disease: a review of
associated lymphoid tissue (MALT) lymphoma. Leuk Lymphoma clinicopathological features, pathogenesis, and differential diagnosis.
47:2096, 2006. Am J Gastroenterol 94:1139, 1999.
20. Beal KP, Yeung HW, Yahalom J: FDG-PET scanning for detection and 40. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, et al: Helicobacter
staging of extranodal marginal zone lymphomas of the MALT type: a pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet
report of 42 cases. Ann Oncol 16:473, 2005. 338:1175, 1991.
21. Hoffmann M, Kletter K, Becherer A, et al: 18F-fluorodeoxyglucose 41. Akamatsu T, Mochizuki T, Okiyama Y, et al: Comparison of localized
positron emission tomography (18F-FDG-PET) for staging and gastric mucosa-associated lymphoid tissue (MALT) lymphoma with
follow-up of marginal zone B-cell lymphoma. Oncology 64:336, 2003. and without Helicobacter pylori infection. Helicobacter 11:86, 2006.
22. Radan L, Fischer D, Bar-Shalom R, et al: FDG avidity and PET/CT 42. Chen LT, Lin JT, Tai JJ, et al: Long-term results of anti-Helicobacter
patterns in primary gastric lymphoma. Eur J Nucl Med Mol Imaging pylori therapy in early-stage gastric high-grade transformed MALT
35:1424, 2008. lymphoma. J Natl Cancer Inst 97:1345, 2005.